PMID- 15553309 OWN - NLM STAT- MEDLINE DCOM- 20050830 LR - 20200225 IS - 0160-9289 (Print) IS - 1932-8737 (Electronic) IS - 0160-9289 (Linking) VI - 27 IP - 10 DP - 2004 Oct TI - Aortic valve replacement in patients 70 years and older. PG - 565-70 AB - BACKGROUND: Aortic valvular disease is the most common valvular lesion among elderly patients. Because of changing demographics, it has become increasingly frequent. Aortic valve replacement (AVR) is the only effective treatment for aortic valvular disease. HYPOTHESIS: This study was undertaken to evaluate the results of AVR in an elderly population. METHODS: Data were retrospectively analyzed in 117 consecutive patients (mean age 73.8 years) who underwent AVR between 1991 and 2002. RESULTS: Pure or predominant severe aortic stenosis was present in 108 patients. Nine patients had severe aortic regurgitation. Before valve replacement, 62.4% of the patients were in New York Heart Association (NYHA) functional class III-IV. A bioprosthesis was implanted in 62.4% of the patients, and 37.6% received a mechanical valve. Concomitant cardiac surgical procedures were performed in 25 patients (coronary artery bypass graft in 22, mitral valve replacement in 3). There were 17 deaths, giving a perioperative mortality rate of 14.5%. Multivariate logistic regression showed that repeat surgery for bleeding, prolonged cardiopulmonary bypass time, postoperative respiratory failure, and postoperative acute renal insufficiency were significant independent predictors of operative mortality. Of the 100 hospital survivors, 78 were followed for a mean of 42.9 months. There were six deaths during follow-up; only two of these were cardiac related. Five-year actuarial survival for all patients and for hospital survivors were 70 and 91.1%, respectively. One year post surgery, all patients were in NYHA functional class I-II. CONCLUSION: In a selected patient population, AVR in the elderly is associated with acceptable mortality and morbidity. The outlook for hospital operative survivors is excellent with improved quality of life and an expected survival normal for this particular age. FAU - Salazar, Eduardo AU - Salazar E AD - Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico, DF. edsalazar00@yahoo.com FAU - Torres, Jorge AU - Torres J FAU - Barragan, Rodolfo AU - Barragan R FAU - Lopez, Mauricio AU - Lopez M FAU - Lasses, Luis Alberto AU - Lasses LA LA - eng PT - Comparative Study PT - Evaluation Study PT - Journal Article PL - United States TA - Clin Cardiol JT - Clinical cardiology JID - 7903272 SB - IM MH - Aged MH - Aortic Valve/*surgery MH - Aortic Valve Insufficiency/*surgery MH - Aortic Valve Stenosis/*surgery MH - Blood Pressure/physiology MH - Cause of Death MH - Coronary Artery Bypass MH - Coronary Artery Disease/surgery MH - Female MH - Follow-Up Studies MH - *Heart Valve Prosthesis Implantation MH - Humans MH - Male MH - Mitral Valve Insufficiency/surgery MH - Multivariate Analysis MH - Postoperative Complications/epidemiology/etiology MH - Retrospective Studies MH - Risk Factors MH - Stroke Volume/physiology MH - Survival Analysis MH - Time MH - Treatment Outcome PMC - PMC6654741 EDAT- 2004/11/24 09:00 MHDA- 2005/09/01 09:00 PMCR- 2006/12/05 CRDT- 2004/11/24 09:00 PHST- 2004/11/24 09:00 [pubmed] PHST- 2005/09/01 09:00 [medline] PHST- 2004/11/24 09:00 [entrez] PHST- 2006/12/05 00:00 [pmc-release] AID - CLC4960271009 [pii] AID - 10.1002/clc.4960271009 [doi] PST - ppublish SO - Clin Cardiol. 2004 Oct;27(10):565-70. doi: 10.1002/clc.4960271009.